ALMR Stock: Price, Earnings History and SEC Filings
Alamar Biosciences, Inc. (ALMR) last traded at $30.60, down 10.11% on the latest session and down 10.2% over the past month. In its most recent reported quarter (Jun 2026) earnings per share were $-0.22 against an analyst estimate of $-0.36, a beat of 38.9%.
Price data from Yahoo Finance, as of Oct 30, 2026. May be delayed.
ALMR earnings history
| Quarter | Reported | EPS | Estimate | Surprise |
|---|---|---|---|---|
| Jun 2026 | Aug 10, 2026 | $-0.22 | $-0.36 | +38.89% |
ALMR beat the analyst EPS estimate in 1 of its last 1 reported quarters. Source: Nasdaq.
Latest SEC filings for ALMR
- 8-K · Sep 1, 2026Officer or director change
- 10-Q · Aug 11, 2026
- 8-K · Aug 10, 2026Results of operations, Financial statements and exhibits
- 8-K · Jul 15, 2026Other events
- 10-Q · May 8, 2026
- 8-K · May 8, 2026Results of operations, Financial statements and exhibits
- 8-K · Apr 20, 2026Bylaw change, Other events, Financial statements and exhibits
- 424B4 · Apr 17, 2026
- S-1 · Mar 27, 2026
Insider filing activity
ALMR insiders filed 7 Form 4 reports in the last 90 days. A Form 4 is how directors and executives disclose purchases, sales and grants of company stock. See the individual filings on SEC EDGAR. Many Form 4 filings are routine, such as scheduled sales or option exercises, so check each filing before drawing a conclusion.
Source: SEC EDGAR.
ALMR news
- Emory Researchers Identify Blood Protein Signature That Detects ALS With 98% Accuracy Using Alamar TechnologyOct 28, 2026 · finance.yahoo.com
- Kardigan And 2 Founder Run Stocks To OwnOct 20, 2026 · finance.yahoo.com
About Alamar Biosciences, Inc.
Alamar Biosciences, Inc. (ALMR) is a US-listed public company on Nasdaq. The SEC classifies its business as Laboratory Analytical Instruments. It is incorporated in DE. Its fiscal year ends in December.